Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery?
FPB-PPC
The Effect of Ultrasound-Guided Fascial Plane Blocks on Postoperative Pulmonary Complications in Patients Undergoing Major Abdominal Surgery: A Prospective Observational Study
1 other identifier
observational
500
1 country
1
Brief Summary
This prospective observational study aims to evaluate whether the use of ultrasound-guided fascial plane blocks is associated with a lower incidence of postoperative pulmonary complications in adult patients undergoing elective major abdominal surgery under general anesthesia. Patients will be observed in two groups based on routine clinical practice: those who receive an ultrasound-guided fascial plane block for postoperative analgesia and those managed with other standard analgesic methods. The choice of analgesic technique will be determined by the responsible anesthesia team and not influenced by the study. Postoperative pulmonary complications occurring within the first 7 days after surgery will be recorded using reopening the European Perioperative Clinical Outcome (EPCO) criteria. Secondary outcomes will include unplanned intensive care unit admission, length of hospital stay, and 30-day mortality. No additional procedures or interventions will be performed for research purposes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 15, 2026
April 30, 2026
April 1, 2026
5 months
January 31, 2026
April 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of postoperative pulmonary complications (PPCs)
Postoperative pulmonary complications will be defined and recorded according to the European Perioperative Clinical Outcome (EPCO) criteria.
Within the first 7 postoperative days
Study Arms (2)
Fascial Plane Block Group
Patients undergoing elective major abdominal surgery who receive an ultrasound-guided fascial plane block at the end of surgery as part of routine clinical practice for postoperative analgesia. The decision to perform the block is made by the responsible anesthesia team and is not influenced by the study protocol.
Control Group
Patients undergoing elective major abdominal surgery who do not receive an ultrasound-guided fascial plane block and are managed with other routine postoperative analgesic methods, including epidural analgesia, intravenous patient-controlled analgesia, or oral analgesics, according to standard clinical practice.
Eligibility Criteria
The study population consists of patients aged 65 years and older who are scheduled to undergo elective major abdominal surgery under general anesthesia. Eligible participants will be managed in a tertiary care hospital and will be allocated to either a fascial plane block group or a control group receiving standard perioperative analgesia. The study aims to evaluate postoperative outcomes in an elderly surgical population with comparable baseline characteristics.
You may qualify if:
- Age 65 years or older
- Scheduled for elective major abdominal surgery (e.g., colorectal, hepatobiliary, pancreatic, or gastric surgery)
- ASA physical status II-III
- Ability to provide written informed consent
- Planned use of general anesthesia with or without adjunct regional techniques
You may not qualify if:
- Refusal or inability to provide informed consent
- Known allergy or contraindication to local anesthetics
- Coagulopathy or ongoing anticoagulant therapy contraindicating regional anesthesia
- Infection at the site of planned block
- Pre-existing chronic opioid use or chronic pain syndrome
- Severe hepatic, renal, or cardiac failure (e.g., Child-Pugh C, end-stage renal disease, EF \<30%)
- Cognitive impairment or severe dementia preventing adequate pain assessment
- Emergency surgery
- Body mass index (BMI \> 40 kg/m²)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital
Yenimahalle, Ankara, 06370, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
arif timuroglu
Dr. Abdurrahman yurtaslan Ankara Oncology Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist in Anesthesiology and Intensive Care
Study Record Dates
First Submitted
January 31, 2026
First Posted
February 6, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 15, 2026
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to institutional policies and concerns regarding patient confidentiality and data protection.